104 related articles for article (PubMed ID: 38739523)
1. Pulsatile gonadotropin releasing hormone therapy for spermatogenesis in congenital hypogonadotropic hypogonadism patients who had poor response to combined gonadotropin therapy.
Huang Z; Wang X; Yu B; Ma W; Zhang P; Wu X; Nie M; Mao J
Arch Endocrinol Metab; 2024 May; 68():e230101. PubMed ID: 38739523
[TBL] [Abstract][Full Text] [Related]
2. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
Liu L; Banks SM; Barnes KM; Sherins RJ
J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
[TBL] [Abstract][Full Text] [Related]
3. Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism.
Mao JF; Liu ZX; Nie M; Wang X; Xu HL; Huang BK; Zheng JJ; Min L; Kaiser UB; Wu XY
Asian J Androl; 2017; 19(6):680-685. PubMed ID: 28051040
[TBL] [Abstract][Full Text] [Related]
4. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases.
Büchter D; Behre HM; Kliesch S; Nieschlag E
Eur J Endocrinol; 1998 Sep; 139(3):298-303. PubMed ID: 9758439
[TBL] [Abstract][Full Text] [Related]
5. Pulsatile Gonadotropin-Releasing Hormone Therapy Is Associated With Better Spermatogenic Outcomes than Gonadotropin Therapy in Patients With Pituitary Stalk Interruption Syndrome.
Zhang J; Zhu Y; Zhang R; Liu H; Sun B; Zhang W; Wang X; Nie M; Mao J; Wu X
Endocr Pract; 2024 Feb; 30(2):146-154. PubMed ID: 38029930
[TBL] [Abstract][Full Text] [Related]
6. Optimal treatment for spermatogenesis in male patients with hypogonadotropic hypogonadism.
Lin J; Mao J; Wang X; Ma W; Hao M; Wu X
Medicine (Baltimore); 2019 Aug; 98(31):e16616. PubMed ID: 31374027
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors for pituitary response to pulsatile GnRH therapy in patients with congenital hypogonadotropic hypogonadism.
Mao JF; Wang X; Zheng JJ; Liu ZX; Xu HL; Huang BK; Nie M; Wu XY
Asian J Androl; 2018; 20(4):319-323. PubMed ID: 29516878
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Pulsatile Gonadotropin-Releasing Hormone Therapy in Male Patients: Comparison between Pituitary Stalk Interruption Syndrome and Congenital Hypogonadotropic Hypogonadism.
Huang Q; Mao J; Wang X; Yu B; Ma W; Ji W; Zhu Y; Zhang R; Sun B; Zhang J; Nie M; Wu X
Endocr Pract; 2022 May; 28(5):521-527. PubMed ID: 35218954
[TBL] [Abstract][Full Text] [Related]
9. Pulsatile gonadotropin-releasing hormone treatment of men with idiopathic hypogonadotropic hypogonadism.
Christiansen P; Skakkebaek NE
Horm Res; 2002; 57(1-2):32-6. PubMed ID: 12006717
[TBL] [Abstract][Full Text] [Related]
10. [Spermatogenesis of pulsatile gonadotropin-releasing hormone infusion versus gonadotropin therapy in male idiopathic hypogonadotropic hypogonadism].
Huang B; Mao J; Xu H; Wang X; Liu Z; Nie M; Wu X
Zhonghua Yi Xue Za Zhi; 2015 May; 95(20):1568-71. PubMed ID: 26463603
[TBL] [Abstract][Full Text] [Related]
11. Comparison of pulsatile subcutaneous gonadotropin-releasing hormone and exogenous gonadotropins in the treatment of men with isolated hypogonadotropic hypogonadism.
Liu L; Chaudhari N; Corle D; Sherins RJ
Fertil Steril; 1988 Feb; 49(2):302-8. PubMed ID: 3123278
[TBL] [Abstract][Full Text] [Related]
12. Correlations Among Genotype and Outcome in Chinese Male Patients With Congenital Hypogonadotropic Hypogonadism Under HCG Treatment.
Chen Y; Sun T; Niu Y; Wang D; Xiong Z; Li C; Liu K; Qiu Y; Sun Y; Gong J; Wang T; Wang S; Xu H; Liu J
J Sex Med; 2020 Apr; 17(4):645-657. PubMed ID: 32171629
[TBL] [Abstract][Full Text] [Related]
13. Gonadotropin treatment for male partial congenital hypogonadotropic hypogonadism in Chinese patients.
Hao M; Nie M; Yu BQ; Gao YJ; Wang X; Ma WL; Huang QB; Zhang R; Mao JF; Wu XY
Asian J Androl; 2020; 22(4):390-395. PubMed ID: 31464203
[TBL] [Abstract][Full Text] [Related]
14. Induction of puberty in a patient with hypogonadotropic hypogonadism: effect of sequentially applied hCG and pulsatile GnRH administration.
Klingmüller D; Menger D; Wildt L; Leyendecker G; Krück F; Schweikert HU
Horm Metab Res; 1985 Jul; 17(7):358-61. PubMed ID: 3928472
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of human chorionic gonadotropin combined with human menopausal gonadotropin and a gonadotropin-releasing hormone pump for male adolescents with congenital hypogonadotropic hypogonadism.
Liu Y; Ren XY; Peng YG; Chen SK; Cheng XR; Qin M; Wang XL; Song YN; Fan LJ; Gong CX
Chin Med J (Engl); 2021 Mar; 134(10):1152-1159. PubMed ID: 33813517
[TBL] [Abstract][Full Text] [Related]
16. Induction of testicular growth and spermatogenesis by pulsatile, intravenous administration of gonadotrophin-releasing hormone in patients with hypogonadotrophic hypogonadism.
Delemarre-Van de Waal HA
Clin Endocrinol (Oxf); 1993 May; 38(5):473-80. PubMed ID: 8330443
[TBL] [Abstract][Full Text] [Related]
17. The Pulsatile Gonadorelin Pump Induces Earlier Spermatogenesis Than Cyclical Gonadotropin Therapy in Congenital Hypogonadotropic Hypogonadism Men.
Zhang L; Cai K; Wang Y; Ji W; Cheng Z; Chen G; Liao Z
Am J Mens Health; 2019; 13(1):1557988318818280. PubMed ID: 30569789
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Outcome Predictors of Gonadotropin Treatment for Male Congenital Hypogonadotropic Hypogonadism: A Retrospective Study of 223 Patients.
Liu Z; Mao J; Wu X; Xu H; Wang X; Huang B; Zheng J; Nie M; Zhang H
Medicine (Baltimore); 2016 Mar; 95(9):e2867. PubMed ID: 26945370
[TBL] [Abstract][Full Text] [Related]
19. Pulsatile gonadotrophin releasing hormone versus gonadotrophin treatment of hypothalamic hypogonadism in males.
Schopohl J
Hum Reprod; 1993 Nov; 8 Suppl 2():175-9. PubMed ID: 8276954
[TBL] [Abstract][Full Text] [Related]
20. Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism--diagnostic and therapeutic aspects.
Delemarre-van de Waal HA
Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U89-94. PubMed ID: 15554892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
